About SpliSense
SpliSense is a company based in Jerusalem (Israel) founded in 2016.. SpliSense has raised $28.5 million across 2 funding rounds from investors including Orbimed, Cystic Fibrosis Foundation and Israel Biotech Fund. SpliSense offers products and services including SPL84, SPL5AC, SPL5B, and SPL23. SpliSense operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and eXmoor, among others.
- Headquarter Jerusalem, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.5 M (USD)
in 2 rounds
-
Latest Funding Round
$28.5 M (USD), Series B
May 13, 2021
-
Investors
Orbimed
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpliSense
SpliSense offers a comprehensive portfolio of products and services, including SPL84, SPL5AC, SPL5B, and SPL23. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets cystic fibrosis using ASOs to modify protein function.
Addresses muco-obstructive diseases through RNA-based interventions.
Focuses on pulmonary conditions via Antisense Oligonucleotides.
Develops treatments for additional pulmonary disease opportunities.
Unlock access to complete
Unlock access to complete
Funding Insights of SpliSense
SpliSense has successfully raised a total of $28.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $28.5 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $28.5M
-
First Round
First Round
(01 Jun 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series B - SpliSense | Valuation | Cystic Fibrosis Foundation , Orbimed | |
| Jun, 2017 | Amount | Grant - SpliSense | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SpliSense
SpliSense has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, Cystic Fibrosis Foundation and Israel Biotech Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Israeli life science ventures are funded by Integra Holdings.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SpliSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SpliSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Splisense Comparisons
Competitors of SpliSense
SpliSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and eXmoor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
Cell and gene therapeutic services are provided to biopharmaceutical firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Splisense
Frequently Asked Questions about SpliSense
When was SpliSense founded?
SpliSense was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is SpliSense located?
SpliSense is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Is SpliSense a funded company?
SpliSense is a funded company, having raised a total of $28.5M across 2 funding rounds to date. The company's 1st funding round was a Grant of $400K, raised on Jun 01, 2017.
What does SpliSense do?
SpliSense was founded in 2016 and is headquartered in Jerusalem, Israel. The companys domain is registered as splisense.com. Limited information is available concerning its industry sector, core operations, or specific services. Details on business activities and geographical scope beyond the founding location are not provided in current records. Further data would be required for a comprehensive overview.
Who are the top competitors of SpliSense?
SpliSense's top competitors include Ori Biotech, MaSTherCell and OBiO Technology.
What products or services does SpliSense offer?
SpliSense offers SPL84, SPL5AC, SPL5B, and SPL23.
Who are SpliSense's investors?
SpliSense has 4 investors. Key investors include Orbimed, Cystic Fibrosis Foundation, Israel Biotech Fund, and Integra Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.